Metagenomi TherapeuticsMGX
13F holders, Q1 2024 (March 31)50holders
3famous investors
$10.52avg. 13F price*
At the end of Q1 2024, 50 institutions reported holding Metagenomi Therapeutics Inc. (MGX) in their 13F filings. The largest holders were Ra Capital Management, L.P. ($18.4M), Novo Holdings A/S ($18.3M) and Farallon Capital Management, L.L.C. ($14.2M). 3 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Metagenomi Therapeutics Inc.
- CUSIP
- 59102M104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 51 | $140.3M |
| Exits | 0 | $0 |
Ownership 50 holders
| Ra Capital Management, L.P. | 0.23% | New | 1,744,415 | $18.4M |
| Novo Holdings A/S | 1.27% | New | 1,739,175 | $18.3M |
| Farallon Capital Management, L.L.C. | 0.09% | New | 1,343,201 | $14.2M |
| PFM Health Sciences, LP | 0.68% | New | 1,267,002 | $13.4M |
| HHLR Advisors, LTD. | 0.18% | New | 777,768 | $8.2M |
| Millennium Management | 0.01% | New | 747,548 | $7.6M |
| Citadel Advisors | 0.01% | New | 723,901 | $7.5M |
| Eventide Asset Management, LLC | 0.10% | New | 583,041 | $6.2M |
| Sozo Ventures GP II, L.P. | 2.09% | New | 581,577 | $6.1M |
| Deep Track Capital, LP | 0.14% | New | 466,232 | $4.9M |
| Pura Vida Investments, LLC | 3.31% | New | 461,283 | $4.9M |
| Point72 Asset Management | 0.01% | New | 371,100 | $3.9M |
| Principal Financial Group Inc. | 0.00% | New | 350,859 | $3.7M |
| Artal Group S.A. | 0.08% | New | 300,000 | $3.2M |
| Frazier Life Sciences Management, L.P. | 0.12% | New | 279,025 | $2.9M |
| ExodusPoint Capital Management, LP | 0.03% | New | 227,556 | $2.4M |
| Marshall Wace, LLP | 0.00% | New | 183,027 | $1.9M |
| Vanguard Group Inc. | 0.00% | New | 179,547 | $1.9M |
| Altitude Crest Partners Inc. | 0.60% | New | 133,333 | $1.4M |
| Ghisallo Capital Management LLC | 0.17% | New | 125,000 | $1.3M |
| BlackRock Inc. | 0.00% | New | 114,324 | $1.2M |
| Norges Bank | 0.00% | New | 107,892 | $1.1M |
| Geode Capital Management, LLC | 0.00% | New | 86,763 | $915K |
| Hudson Bay Capital Management LP | 0.01% | New | 66,666 | $703K |
| LMR Partners LLP | 0.02% | New | 52,058 | $549K |
| HRT Financial LP | 0.00% | New | 31,477 | $332K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 30,148 | $318K |
| Squarepoint Ops LLC | 0.00% | New | 26,488 | $279K |
| Bramshill Investments, LLC | 0.03% | New | 25,500 | $269K |
| Wells Fargo & Company | 0.00% | New | 24,894 | $263K |
| Balyasny Asset Management L.P. | 0.00% | New | 22,009 | $232K |
| Two Sigma Investments, LP | 0.00% | New | 20,159 | $213K |
| Laurion Capital Management LP | 0.01% | New | 20,000 | $211K |
| Citigroup Inc. | 0.00% | New | 16,668 | $176K |
| Qube Research & Technologies Ltd | 0.00% | New | 16,667 | $176K |
| JPMorgan Chase & Co. | 0.00% | New | 13,747 | $145K |
| Northern Trust Corp. | 0.00% | New | 13,053 | $138K |
| Jane Street Group, LLC | 0.00% | New | 12,330 | $130K |
| Teacher Retirement System of Texas | 0.00% | New | 10,000 | $106K |
| Legal & General Group Plc | 0.00% | New | 10,000 | $106K |
| Resolute Advisors LLC | 0.02% | New | 10,000 | $106K |
| Morgan Stanley | 0.00% | New | 9,205 | $97K |
| US Bancorp \de | 0.00% | New | 4,500 | $47K |
| Bank of America Corp. | 0.00% | New | 3,149 | $33K |
| UBS Group AG | 0.00% | New | 1,680 | $18K |
| Assetmark, Inc. | 0.00% | New | 952 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 456 | $5K |
| Principal Securities, Inc. | 0.00% | New | 54 | $570 |
| Larson Financial Group LLC | 0.00% | New | 50 | $528 |
| Macquarie Group Ltd. | 0.00% | New | 355 | $4 |
"% of holder's portfolio" is MGX's weight in each manager's 13F, not the share of Metagenomi Therapeutics Inc. the manager owns.